Overview

* MetLife Q3 2025 revenue missed analyst expectations

* Adjusted EPS for Q3 2025 beats analyst expectations

* Company returned $875 mln to shareholders via repurchases and dividends

Outlook

* Company did not provide specific guidance for future quarters in its press release

Result Drivers

* VARIABLE INVESTMENT INCOME - Higher private equity returns significantly boosted variable investment income, contributing to a 15% increase in adjusted earnings

* PENSION RISK TRANSFERS - Secured $12 bln in pension risk transfer mandates in Q4, enhancing future revenue potential

* ASIA SALES GROWTH - Asia sales grew 34% on a constant currency basis, driven by new retirement-oriented products in Japan and other markets

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $17.36 $18.81

Revenue bln bln (6

Analysts

)

Q3 Beat $2.37 $2.32

Adjusted (15

EPS Analysts

)

Q3 EPS $1.22

Q3 $1.58

Adjusted bln

Net

Income

Q3 Net $818 mln

Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the life & health insurance peer group is "buy"

* Wall Street's median 12-month price target for MetLife Inc ( MET ) is $95.50, about 16.8% above its November 4 closing price of $79.46

* The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)